Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
10.1093/narcan/zcae004 · doi-reference
Metabolite-dependent m6A methylation driven by mechanotransduction-metabolism-epitranscriptomics axis promotes bone development and regeneration
10.1016/j.celrep.2025.115611 · doi-reference
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
10.1038/nature08617 · doi-reference
Enhancing temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O6-methylguanine DNA methyltransferase (MGMT)
10.1007/s11060-024-04708-0 · doi-reference
Phase I trial of Temozolomide plus O6 -benzylguanine for patients with recurrent or progressive malignant glioma
10.1200/jco.2005.06.502 · doi-reference
Changes of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in glioblastoma relapse—A meta-analysis type literature review
10.3390/cancers11121837 · doi-reference
The changes in MGMT promoter methylation status in initial and recurrent glioblastomas
10.1593/tlo.12253 · doi-reference
Regulatory mechanisms of O6-methylguanine methyltransferase expression in glioma cells
10.1177/00368504251345014 · doi-reference
Posttranslational regulation of O6-methylguanine–DNA methyltransferase (MGMT) and new opportunities for treatment of brain cancers
10.2174/1389557515666150722101046 · doi-reference
The SMAD2/3 interactome reveals that tgfβ controls m6A mRNA methylation in pluripotency
10.1038/nature25784 · doi-reference
RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation
10.1038/s41556-023-01213-w · doi-reference
METTL3 and N6-methyladenosine promote homologous recombination-mediated repair of DSBs by modulating DNA-RNA hybrid accumulation
10.1016/j.molcel.2020.06.017 · doi-reference
METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma
10.1038/s44318-024-00299-8 · doi-reference
PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms
10.1016/j.celrep.2025.115484 · doi-reference
Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis
10.1172/jci175703 · doi-reference
TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway
10.1038/onc.2013.593 · doi-reference
IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma
10.1007/s12094-019-02251-3 · doi-reference
Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells
10.1186/s10020-019-0116-z · doi-reference
PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1α from pVHL-independent degradation
10.1074/jbc.m310164200 · doi-reference
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
10.1038/nature07385 · doi-reference
RBPmap: a web server for mapping binding sites of RNA-binding proteins
10.1093/nar/gku406 · doi-reference
Transcriptome-wide identification of RNA-binding protein binding sites using seCLIP-seq
10.1038/s41596-022-00680-z · doi-reference
Identification of m6A residues at single-nucleotide resolution using eCLIP and an accessible custom analysis pipeline
10.1261/rna.078543.120 · doi-reference
N6-Methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer
10.1016/j.ymthe.2024.10.025 · doi-reference
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation
10.1016/j.celrep.2024.114165 · doi-reference
The METTL5-TRMT112 N(6)-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation
10.1016/j.jbc.2022.101590 · doi-reference
The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA
10.1093/nar/gkz1147 · doi-reference
N(6-)methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation
10.1038/s41589-018-0184-3 · doi-reference
The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112
10.1093/nar/gkz619 · doi-reference
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges
10.1093/neuonc/noy132 · doi-reference
Comparative Toxicogenomics Database’s 20th anniversary: update 2025
10.1093/nar/gkae883 · doi-reference
Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression
10.1186/s12885-024-12751-3 · doi-reference
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
10.20517/cdr.2020.79 · doi-reference
Next-generation characterization of the Cancer Cell Line Encyclopedia
10.1038/s41586-019-1186-3 · doi-reference
Transcription-wide mapping of dihydrouridine reveals that mRNA dihydrouridylation is required for meiotic chromosome segregation
10.1016/j.molcel.2021.11.003 · doi-reference
A user guide to RT-based mapping of RNA modifications
10.1016/bs.mie.2024.07.006 · doi-reference
STREME: accurate and versatile sequence motif discovery
10.1093/bioinformatics/btab203 · doi-reference
PureCLIP: capturing target-specific protein–RNA interaction footprints from single-nucleotide CLIP-seq data
10.1186/s13059-017-1364-2 · doi-reference
Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges
10.1038/nsmb.2699 · doi-reference
An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells
10.1038/nsmb.1545 · doi-reference
